Scripps

A man wearing a Fitbit Charge 2 device
By  Dave Muoio 11:18 am November 2, 2020
Symptom-based COVID-19 screening can be improved by incorporating data collected from wearable sensors into prediction algorithms, an approach that could complement ongoing testing efforts by spotting symptomatic and pre-symptomatic individuals early, according to a research letter recently published in nature medicine. The findings are part of the DETECT (Digital Engagement and Tracking for...
By  Dave Muoio 04:04 pm March 27, 2020
Two medical research organizations have kicked off new efforts this week that seek to use consumer-health wearables to identify or event predict the onset of disease. The first is the DETECT (Digital Engagement & Tracking for Early Control & Treatment) Study, headed by the Scripps Research Translational Institute. It combines heart-rate, activity and sleep data collected through a range...
By  Dave Muoio 03:41 pm January 20, 2020
Resting heart rate and sleep duration data collected from Fitbit devices could help inform timely and accurate models of population-level influenza trends, according to a new Scripps Research Translational Institute study published online in The Lancet Digital Health last Friday. “Currently, CDC [influenza-like illness (ILI)] data are typically reported [one to three] weeks late and reported...
By  Dave Muoio 04:06 pm May 30, 2019
It’s little exaggeration to say that the healthcare industry has been transformed by new technologies. Automation, big data analysis, consumer-facing digital tools and more are steadily becoming the norm in daily care, and by and large come with promises of better outcomes and lower costs. But not every new technology that’s made it to the big show has been a home run, however, and just about...
By  Laura Lovett 02:58 pm April 4, 2018
Last year Katherine Kaiser graduated from Stanford University, incidentally meaning she also “graduated” from the Stanford health system. It was time to shop around for new doctors in her area, but that meant her medical records would potentially be scattered across different healthcare systems.  An analyst at a healthcare consulting firm, Kaiser is always tracking new tech. So she was interested...
By  Tom Sullivan 03:16 pm October 30, 2017
The Scripps Research Institute on Wednesday announced a new smartphone app that can calculate a user’s risk of heart disease. Hospitals will want to keep an eye on the research study that Scripps conducts about the effectiveness of giving patients predictions concerning adverse health events and what impact that could have on influencing healthy behaviors and lifestyle changes. Scripps MyGeneRank...
By  Jonah Comstock 09:57 am October 6, 2016
The National Institutes of Health has expanded the $120 million grant it planned to give a consortium led by the Scripps Translational Science Institute. The award, which will be distributed over the next five years, has been expanded to $207 million, though the new funds also come with new responsibilities for the consortium as part of the White House's Precision Medicine Initiative. “The size...
By  Heather Mack 03:18 pm August 11, 2016
Medical technology company ImpediMed launched a direct-to-consumer connected device that tracks body composition, fluid status and hydration in a variety of settings. SOZO is two-pound, sensor-enabled scale with a connected stand and platform cradle to rest either a tablet or smartphone. The users steps on the scale, which has eight body sensors and four weight sensors, waits a few seconds and...
By  Jonah Comstock 04:31 pm January 19, 2016
The results are in for the Scripps Translational Science Institute’s Wired For Health study, and there’s no sugar-coating it: they’re disappointing for those working in digital health. The six-month randomized control trial found no short-term benefit in health costs or outcomes for patients monitoring their health with connected devices.  “It was a bit disappointing, but remember, this was the...
By  Jonah Comstock 10:55 am November 30, 2015
The Scripps Translational Science Institute is working with Aetna and Johnson & Johnson to launch a trial that will test iRhythm's Zio Patch and the Amiigo activity tracker as possible new ways to screen at-risk populations for atrial fibrillation. "What we really want at the end of this study is to be able to best understand what the right way is to screen high-risk patients for atrial...